Full Text
Full Text PDF
Abstract
Renal involvement is the cause of major mortality and morbidity of systemic lupus erythematosus (SLE) disease. Although regimes including pulse cyclophosphamide and corticosteroid are the most effective treatment modalities, they are not ideal for toxicity. The increase in neoplasm risk, infections and gonadal toxicity are the major concerns about cyclophosphamide. While choosing the treatment of severe lupus nephritis, risk benefit ratio should be thought individually. Clinical status, activity degree, chronicity in renal histology, tolerability of the patient, presence of infection, cytopenia, extrarenal involvement should be evaluated in detail. The treatment of lupus nephritis was discussed with this review.
Similar Articles
Article Info
Published In
Journal
Turkish Journal of Nephrology
Volume / Issue
Volume 15 · Issue 2
Pages
71-76
History
Published Online
February 14, 2019
Copyright
Copyright (c) 2006 Turkish Journal of Nephrology
Affiliations
Kübra KAYNAR
Karadeniz Teknik Üniversitesi Tıp Fakültesi, İç Hastalıkları AD, Nefroloji BD, Trabzon
Cite this Article
KAYNAR, K. (2019). Treatment of Lupus Nephritis. Turkish Journal of Nephrology, 15(2), 71–76. Retrieved from https://www.turkjnephrol.org/index.php/pub/article/view/519
Outlines